Name: Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension (Video) | JoVE Journal
Uploaded: 2025-06-06T14:05:00.000+00:00
Duration: 4 min 37 s
Description: Learn CT-guided ozone-mediated renal denervation for resistant hypertension using lumbar ganglia targeting. This less invasive technique improves blood pressure control while avoiding renal artery access and contrast agents.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This study is funded by Guangzhou Municipal Science and Technology Bureau (2023A03J0984 and 2024A03J0654).

This study was approved by the Guangzhou Red Cross Hospital Ethics Board (No. 2022-145-01), and written informed consent was obtained from all participants prior to enrollment. This single-arm clinical trial was designed and registered in Chictr.org.cn (ChiCTR2300071375).
1. Study design
NOTE: This was a prospective, single-arm clinical study aimed at observing the home BP control rate in patients before and after the procedure.
<ol>
	<li>Set the following inclusive criteria: age between 18 and 80 years; hypertensive patients with BP that remains elevated above 140/90 mmHg even with the simultaneous use of three antihypertensive medications from different classes, commonly including a diuretic; or patients whose BP achieves less than 140/90 mmHg on &#8805;4 antihypertensive medications.</li>
	<li>Exclude the following patients: diagnosed secondary hypertension; spinal deformities or infective; prior renal artery angioplasty or catheter-based denervation; previous lumbar internal vertebral disc radiofrequency ablation or sympathetic blockage; and a history of myocardial infarction, cerebral vascular accident, or transient ischemic attack within 3 months before enrollment; patients who did not upload the scales in a timely manner as required during the follow-up period.</li>
	<li>Evaluation of antihypertensive medication burden (AHMB)
	<ol>
		<li>Assess the antihypertensive medication burden by counting the number of medication classes, disregarding the doses. When the criteria for medication reduction are met, consider discontinuing one class of medication, regardless of dosage, as reducing one burden. To maintain adherence and prevent unproven medication changes, have the follow-up team verify the medication plan with patients weekly and ensure those eligible for reduction are following the prescribed adjustments.</li>
	</ol>
	</li>
	<li>Set the criteria for reducing antihypertensive drugs as systolic blood pressure (SBP) &#8804; 110 mmHg on at least two consecutive measurements after the procedure.</li>
	<li>Home BP monitor
	<ol>
		<li>To ensure the accuracy of home BP measurement, train all patients formally to measure their home BP at four different time points each day in a standardized manner: upon waking, at 10:00 AM, at 4:00 PM, and before bedtime. Request that patients log their home BP readings on a record form, which will be collected by the study team every week during follow-up.Define home BP control as SBP of &#8804;140 mmHg and a diastolic blood pressure (DBP) of &#8805;90 mmHg. 
		NOTE: An electronic automatic device was used to measure brachial artery BP.</li>
	</ol>
	</li>
	<li>Safety: Report and record all possible adverse events via phone calls, messaging apps, or in the outpatient clinic. Potential complications include orthostatic hypotension, gastrointestinal dysfunction, dysuria, and male erectile dysfunction.</li>
</ol>
2. Preparation before the procedure (prone position training for patients in the ward)
<ol>
	<li>Have the patient assume a prone position on the bed, extending their arms parallel above the head.</li>
	<li>Place a pillow beneath the lower abdomen to flatten the lumbar curve, ensuring the back and buttocks are on the same level. 
	NOTE: Pillow placement may vary according to individual body types.</li>
	<li>Carry out this exercise twice a day for 2-3 days with the aim of keeping the position stationary for at least 20 min.</li>
</ol>
3. Ozone-mediated renal denervation (in CT laboratory)
<ol>
	<li>Remove the patient&#39;s upper garment to expose the torso.</li>
	<li>Attach the electrodes and connect to an electrocardiogram monitor.</li>
	<li>Measure the supine blood pressure.</li>
	<li>Have the patient switch to a prone position, ensuring comfort and stability.</li>
	<li>For reference points on the body surface, place a metal wire on the midline of the torso (approximately at T12-L3 level) to act as a reference for the deviation distance from the midline of the body surface puncture point under CT guidance (Point C in Figure 1).</li>
	<li>Identify the puncture target
	<ol>
		<li>Use a CT scanner to get anteroposterior and lateral images of the lumbar spine (range: S2 to T11) for vertebral counting and transitional vertebrae assessment.</li>
		<li>On the transverse images, identify the left renal artery origin level and determine the injection target point (Point A in Figure 1) at the anterolateral third of the vertebral right edge at this level. 
		NOTE: If the renal artery is directly below the transverse process at the same level, adjust the injection level to avoid the transverse process.</li>
		<li>Record the corresponding transverse plane position.</li>
	</ol>
	</li>
	<li>CT-guided puncture parameter measurement
	<ol>
		<li>On the selected transverse image in step 3.6.2, identify injection target point A (Figure 1) at the anterolateral third of the vertebral side. 
		NOTE: The target point should be below the fascia of the ipsilateral psoas major muscle, ~2-3 mm away from the left renal artery.</li>
		<li>Draw a line from A along the outer lateral border of the left psoas major. The intersection of this line with the body surface is the skin puncture point B, with the metal wire on the lumbar body surface corresponding to point C. Measure the length of AB (needle insertion depth), the angle between AB and BC (puncture angle Q), and the length of BC (lateral distance of the body surface puncture point from the midline (Figure 1)). 
		NOTE: Ensure that the needle remains entirely within the psoas major throughout its trajectory.</li>
	</ol>
	</li>
	<li>Surface puncture point positioning
	<ol>
		<li>Adjust the bed to the recorded position in step 3.6.2. Activate the laser positioning line and mark two lines using a marker: one along the projection line (A line) and the other along the preplaced metal line on the body surface midline (B line). The intersection of these two lines is point C in step 3.5.</li>
		<li>Remove the metal wire and mark the puncture point B on line A according to the BC segment length measured in step 3.7.</li>
	</ol>
	</li>
	<li>Puncture protocol
	<ol>
		<li>Insert a 21 G needle with length markers at point B, puncturing at the predetermined angle to the predicted depth. Perform continuous 2 mm slice thickness scans around the puncture point &#177; 0.4-0.8 cm to confirm the needle tip. 
		NOTE: If resistance is encountered, indicating an excessive puncture angle and needle-vertebra contact, retract and readjust the puncture angle under CT guidance.</li>
		<li>Connect a 10 mL syringe, ensure no blood or gas is aspirated, and then inject 2 mL of 10% ropivacaine. Use a 20 mL syringe to draw 10 mL of O2-O3 gas mixture from a medical ozone generator and inject slowly along the needle. Repeat the CT scan to show ozone distribution. 
		NOTE: The ozone concentration is 30 &#181;g/mL.</li>
	</ol>
	</li>
	<li>After the procedure, ask the patient to lie in a supine position, and measure cuff BP every 5 min. Ensure that the monitoring in the CT room lasts for at least 20 min.</li>
</ol>

<ol><li>Carey, R. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Resistant+hypertension%3A+Detection%2C+evaluation%2C+and+management%3A+A+scientific+statement+from+the+American+Heart+Association%5BTitle%5D)+AND+%22Hypertension%22%5BJournal%5D)">Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association.</a> Hypertension. 72 (5), e53-e90 (2018).</li>
<li>Irvin, M. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Apparent+treatment-resistant+hypertension+and+risk+for+stroke%2C+coronary+heart+disease%2C+and+all-cause+mortality%5BTitle%5D)+AND+%22J+Am+Soc+Hypertens%22%5BJournal%5D)">Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.</a> J Am Soc Hypertens. 8 (6), 405-413 (2014).</li>
<li>Crile, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+clinical+results+of+celiac+ganglionectomy+in+the+treatment+of+essential+hypertension%5BTitle%5D)+AND+%22Ann+Surg%22%5BJournal%5D)">The clinical results of celiac ganglionectomy in the treatment of essential hypertension.</a> Ann Surg. 107 (6), 909-916 (1938).</li>
<li>Smithwick, R. H., Thompson, J. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Splanchnicectomy+for+essential+hypertension%3B+results+in+1%2C266+cases%5BTitle%5D)+AND+%22J+Am+Med+Assoc%22%5BJournal%5D)">Splanchnicectomy for essential hypertension; results in 1,266 cases.</a> J Am Med Assoc. 152 (16), 1501-1504 (1953).</li>
<li>Bhatt, D. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Long-term+outcomes+after+catheter-based+renal+artery+denervation+for+resistant+hypertension%3A+Final+follow-up+of+the+randomised+SYMPLICITY+HTN-3+trial%5BTitle%5D)+AND+%22Lancet%22%5BJournal%5D)">Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: Final follow-up of the randomised SYMPLICITY HTN-3 trial.</a> Lancet. 400 (10361), 1405-1416 (2022).</li>
<li>Vinayak, M., Olin, J. W., Stone, G. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+ongoing+odyssey+of+renal+denervation%5BTitle%5D)+AND+%22J+Am+Coll+Cardiol%22%5BJournal%5D)">The ongoing odyssey of renal denervation.</a> J Am Coll Cardiol. 82 (19), 1824-1827 (2023).</li>
<li>Hering, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transurethral+renal+pelvic+denervation%3A+A+feasibility+trial+in+patients+with+uncontrolled+hypertension%5BTitle%5D)+AND+%22Hypertension%22%5BJournal%5D)">Transurethral renal pelvic denervation: A feasibility trial in patients with uncontrolled hypertension.</a> Hypertension. 79 (12), 2787-2795 (2022).</li>
<li>Luo, G., Zhu, J. J., Yao, M., Xie, K. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Computed+tomography-guided+chemical+renal+sympathetic+nerve+modulation+in+the+treatment+of+resistant+hypertension%3A+A+case+report%5BTitle%5D)+AND+%22World+J+Clin+Cases%22%5BJournal%5D)">Computed tomography-guided chemical renal sympathetic nerve modulation in the treatment of resistant hypertension: A case report.</a> World J Clin Cases. 9 (32), 9970-9976 (2021).</li>
<li>Gao, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Laparoscopic-based+perivascular+unilateral+renal+sympathetic+nerve+denervation+for+treating+resistant+hypertension%3A+A+case+report%5BTitle%5D)+AND+%22Hypertens+Res%22%5BJournal%5D)">Laparoscopic-based perivascular unilateral renal sympathetic nerve denervation for treating resistant hypertension: A case report.</a> Hypertens Res. 42 (8), 1162-1165 (2019).</li>
<li>Ricke, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Renal+sympathetic+denervation+by+CT-guided+ethanol+injection%3A+A+phase+ii+pilot+trial+of+a+novel+technique%5BTitle%5D)+AND+%22Cardiovasc+Intervent+Radiol%22%5BJournal%5D)">Renal sympathetic denervation by CT-guided ethanol injection: A phase ii pilot trial of a novel technique.</a> Cardiovasc Intervent Radiol. 39 (2), 251-260 (2016).</li>
<li>Kirkpatrick, J. J., Foutz, S., Leslie, S. W. Anatomy, abdomen and pelvis: Kidney nerves. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aKirkpatrick%2C+JJ+%22StatPearls%22">StatPearls</a>. , StatPearls Publishing LLC. Treasure Island, FL. (2022).</li>
<li>García-Touchard, A., Sañudo, J. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Renal+denervation.+Importance+of+knowledge+of+sympathetic+nervous+system+anatomy+in+refining+the+technique%5BTitle%5D)+AND+%22Rev+Esp+Cardiol+%28Engl+Ed%29%22%5BJournal%5D)">Renal denervation. Importance of knowledge of sympathetic nervous system anatomy in refining the technique.</a> Rev Esp Cardiol (Engl Ed). 72 (7), 531-534 (2019).</li>
<li>Orlandin, J. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Evaluation+of+targeted+oxidative+stress+induced+by+oxygen-ozone+in+vitro+after+ischemic+induction%5BTitle%5D)+AND+%22Redox+Rep%22%5BJournal%5D)">Evaluation of targeted oxidative stress induced by oxygen-ozone in vitro after ischemic induction.</a> Redox Rep. 27 (1), 259-269 (2022).</li>
<li>Li, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ct-guided+ozone-mediated+lumbar-renal+sympathetic+denervation+for+resistant+hypertension+treatment%3A+A+pilot+single-arm+clinical+trial%5BTitle%5D)+AND+%22Cardiovasc+Revasc+Med%22%5BJournal%5D)">Ct-guided ozone-mediated lumbar-renal sympathetic denervation for resistant hypertension treatment: A pilot single-arm clinical trial.</a> Cardiovasc Revasc Med. 67, 51-57 (2024).</li>
</ol>

The authors have no financial conflicts of interest to declare.

Our previous study demonstrated that ozone-mediated RDN significantly reduced in-hospital, office, and ambulatory BP, as well as antihypertensive medication use. The BP reduction was rapid and persisted through the 12 weeks follow-up. Additionally, we observed that the BP-lowering effect was particularly noteworthy in patients with normal baseline renal function14. In this study, CT-guided ozone-mediated RDN showed the effect of improved home BP control for patients with RH.
<p class="jove_con...

Resistant hypertension (RH) is diagnosed when individuals do not meet BP targets despite taking three antihypertensive medications, or when individuals achieve the BP target but require four or more antihypertensive medications1. RH is linked to a significantly higher risk of cardiovascular and renal adverse events2. Renal sympathetic denervation (RDN) -- from surgical sympathectomy or the current catheter-based RDN -- was demonstrated to be effective in the treatment of RH3,4,5.
Due to the invasiveness and severe side effects, surgical sympathectomy has been eliminated. There are still some limitations for catheter-based RDN, including contrast-dependence, potential renal artery injury, relatively lower cost-effectiveness, and the requirement of special catheter assistance6. These limitations highlight the need for improved RDN approaches. In recent years, other RDN techniques, such as CT-guided perivascular ethanol-mediated RDN, transurethral laparoscopic-based RDN, and laparoscopic-based perivascular unilateral RDN have been introduced, demonstrating effective BP reduction7,8,9,10.
The sympathetic ganglion, especially ganglia from T9-L2, are important components of renal sympathetic innervation and are convenient to target under CT guidance11,12. The smpathetic ganglion was the earliest target for RDN in surgery. A recent animal experiment has shown that the injection of ethanol in the celiac trunk ganglion resulted in significant BP reduction. High concentrations of ozone (18-30 &#181;g/mL) promote an increase in the rates of apoptosis and neuroblast cell death13. Our previous trial showed that CT-guided ozone-mediated RDN effectively lowered office and ambulatory BP 12 weeks post procedure in RH patients14. In this study, we evaluate the changes in anti-hypertensive regimen and the effect of home BP control rate of this approach of RDN.

<table><tbody><tr><td>CT scanner</td><td>General Electrics, Hi Speed ZX/I. USA</td><td></td><td></td></tr><tr><td>Graduated measuring tape</td><td>no specified brand</td><td></td><td></td></tr><tr><td>Marker pen</td><td>no specified brand</td><td></td><td></td></tr><tr><td>Medical ozone generator</td><td>Medozon compact, Herrmann Apparatebau GmbH. Germany</td><td></td><td></td></tr><tr><td>Metal wire</td><td>no specified brand</td><td></td><td></td></tr><tr><td>Peit needle</td><td>Hakko Co., Ltd. JAPAN</td><td>21 G x 150 mm</td><td></td></tr><tr><td>Ropivacaine Hydrochloride Injection</td><td>AstraZeneca AB</td><td>100 mg/10 mL</td><td></td></tr><tr><td>Single-use puncture pack</td><td>no specified brand</td><td></td><td>&amp;nbsp;containing sterile cotton swabs, sterile gauze, sterile surgical drape, a 5 mL syringe, and a 20 mL syringe.</td></tr></tbody></table>

improved home blood pressure control by ct-guided ozone-mediated renal denervation for patients with resistant hypertension

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Accumulating evidence from clinical trials in recent years has consistently supported the blood pressure (BP)-lowering efficacy of renal sympathetic denervation (RDN). However, the most widely used catheter-based RDN technique still has limitations in clinical practice. Therefore, it is necessary to develop an alternative RDN approach for BP control. In our previous clinical trial, we demonstrated that CT-guided ozone-mediated RDN effectively reduced both office and ambulatory BP at 12 weeks post procedure in patients with resistant hypertension (RH). In this study, we further evaluated the efficacy of this technique in home BP control of 15 patients with RH. Based on the reduced use of anti-hypertension drugs following the procedure, the control rates of home BP (&#60;140/90 mmHg) for the overall cohort were 60.0%/93.3%, 80.0%/100%, and 80.0%/100% at weeks 4, 8, 12, respectively, and 57.1%/90.91, 81.8%/100% and 90.9%/100% at weeks 4, 8, 12 for patients with normal baseline renal function. Additionally, 33.3% patients achieved the optimal morning BP target of &#8804;135/85 mmHg. No complications were reported intra- or post procedure. We present a simplified, unilaterally operated, contrast-free RDN technique that avoids renal artery injury in the management of RH.

Baseline characteristics: 
Initially, 20 patients were selected. Two patients diagnosed with renal artery stenosis and one with sleep apnea syndrome were excluded, resulting in 17 patients eligible for inclusion. Of these 17 patients, two were unable to continue in the follow-up. Finally, 15 patients were included in this clinical observation, with an age of 65.1 ± 10.8 years. Six patients (6/15; 40.0%) had chronic kidney dysfunction and one (1/15; 5.9%) was on dialysis at the time of enrollment. Elev...

CT-guided ozone-mediated renal denervation (RDN) by injecting an O2-O3 gas mixture around lumbar ganglia reduces antihypertensive medication burden and achieves an improved home blood pressure control rate. We present a novel, simplified, unilateral, and contrast-free RDN technique that minimizes the renal artery injury in the treatment of patients with resistant hypertension (RH).

Accumulating evidence from clinical trials in recent years has consistently supported the blood pressure (BP)-lowering efficacy of renal sympathetic ...

improved-home-blood-pressure-control-ct-guided-ozone-mediated-renal

Research

JoVE Journal

Medicine

This video demonstrates a procedure for renal artery sympathetic denervation in an angiotensin II-induced hypertensive mouse model, using phenol to disrupt sympathetic nerve function and reduce blood pressure.

Sympathetic Denervation of Renal Arteries in an Angiotensin II-Induced Hypertension Mouse Model

A two-stage method to establish chronic kidney disease (CKD) in the Lewis rat by surgically removing 5/6th of renal mass is described. Combination of the surgical procedure, NOS-inhibition and a high-salt diet leads to a model resembling human CKD, allowing study of causal mechanisms and development of novel therapeutic interventions.

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Vascular cell functiondepends on activity of intracellular messengers.  Described here is an ex vivo two photon imaging method that allows the measurement of intracellular calcium and nitric oxide levels in response to physiological and pharmacological stimuli in individual endothelial and smooth muscle cells of an isolated aorta.

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta

A modified 2 kidney 1 clip (2K1C) Goldblatt mouse model was developed using polyurethane tubing to initiate renal artery stenosis, inducing an increase in renin expression and kidney injury. Here, we describe a detailed procedure of preparing and placing the cuff onto the renal artery to generate a reproducible and consistent 2K1C mouse model.

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Here, we present a protocol for renal sympathetic denervation (RDN) in mice with hypertension induced by Angiotensin II infusion. The procedure is repeatable, convenient and allows to study the regulatory mechanisms of RDN on hypertension and cardiac hypertrophy.

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Presented here is a protocol to measure renal oxygenation in the medulla and noninvasive urine oxygen partial pressure in a hemorrhagic shock porcine model to establish urine oxygen partial pressure as an early indicator of acute kidney injury (AKI) and a novel resuscitative endpoint.

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Our experiment will show how to perform a sequencing analysis of bacterial species translocating in peripheral blood of HIV positive patients.

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Chronic catheterization of blood vessels in the rat is often required for administration of substances, obtain blood sample over a period of time or for direct conscious blood pressure measurements.  Femoral arterial catheterization of the rat and corresponding measurements of blood pressure in the conscious animal will be demonstrated.

Femoral Arterial and Venous Catheterization for Blood Sampling, Drug Administration and Conscious Blood Pressure and Heart Rate Measurements

Individuals with intermittent claudication exhibit poor balance compared to healthy controls. Computerized dynamic posturography is an objective method for measuring an individual's postural responses to balance disturbances. This provides an objective reflection of the person’s ability to respond to situations under which sensory stimuli are altered and unexpected perturbations occur.

Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication

The degree of vascular dysfunction and contributing physiological mechanisms can be assessed in patients with chronic kidney disease by measuring brachial artery flow-mediated dilation, aortic pulse-wave velocity, and vascular endothelial cell protein expression.

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Learn CT-guided ozone-mediated renal denervation for resistant hypertension using lumbar ganglia targeting. This less invasive technique improves blood pressure control while avoiding renal artery access and contrast agents.

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Explore More Videos